AstraZeneca, Bicycle Launch $1B+ Bicyclic Peptide Collaboration
AstraZeneca will partner with Bicycle Therapeutics to develop respiratory, cardiovascular, and metabolic disease treatments based on Bicycle’s proprietary bicyclic peptide (Bicycle®) product platform through a…
Read guide →